Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebban

Showing results (411-420 of 459) with videos related to

Pageof 46
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'AdulteP Solal-Céligny, P Brice, N Brousse, et al.
Haematologica|May 7, 2013
Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphomaEmmanuel Bachy, Roch Houot, Franck Morschhauser, et al.
Bone Marrow Transplantation|June 14, 2006
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphomaD Coso, C Sebban, O Boulat, et al.
Hematological Oncology|March 8, 2011
Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case seriesSawyna Provencher, Céline Ferlay, Khaoula Alaoui-Slimani, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2012
CD4 lymphopenia to identify end-of-life metastatic cancer patientsJulien Péron, Claire Cropet, Olivier Tredan, et al.
Blood|October 6, 2021
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trialsCarla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, et al.
Journal of Adolescent and Young Adult Oncology|August 15, 2019
Pattern of Care and Outcomes of Adolescent and Young Adults with Lymphoma Treated in the Rhône-Alpes RegionArthur Dony, Amine Belhabri, Yves Bertrand, et al.
Optics Letters|August 18, 2009
Aberration-free laser beam in the soft x-ray rangeJ Ph Goddet, S Sebban, J Gautier, et al.
Physical Review Letters|April 6, 2001
Saturated amplification of a collisionally pumped optical-field-ionization soft X-ray laser at 41.8 nmS Sebban, R Haroutunian, P Balcou, et al.
Experimental Hematology|July 25, 2000
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitutionM Michallet, T Philip, I Philip, et al.
Pageof 46

Showing results (411-420 of 459) with videos related to

Sort By:
Pageof 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'AdulteP Solal-Céligny, P Brice, N Brousse, et al.
Haematologica|May 7, 2013
Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphomaEmmanuel Bachy, Roch Houot, Franck Morschhauser, et al.
Bone Marrow Transplantation|June 14, 2006
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphomaD Coso, C Sebban, O Boulat, et al.
Hematological Oncology|March 8, 2011
Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case seriesSawyna Provencher, Céline Ferlay, Khaoula Alaoui-Slimani, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2012
CD4 lymphopenia to identify end-of-life metastatic cancer patientsJulien Péron, Claire Cropet, Olivier Tredan, et al.
Blood|October 6, 2021
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trialsCarla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, et al.
Journal of Adolescent and Young Adult Oncology|August 15, 2019
Pattern of Care and Outcomes of Adolescent and Young Adults with Lymphoma Treated in the Rhône-Alpes RegionArthur Dony, Amine Belhabri, Yves Bertrand, et al.
Optics Letters|August 18, 2009
Aberration-free laser beam in the soft x-ray rangeJ Ph Goddet, S Sebban, J Gautier, et al.
Physical Review Letters|April 6, 2001
Saturated amplification of a collisionally pumped optical-field-ionization soft X-ray laser at 41.8 nmS Sebban, R Haroutunian, P Balcou, et al.
Experimental Hematology|July 25, 2000
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitutionM Michallet, T Philip, I Philip, et al.
Pageof 46